Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

SHINECO Return on Tangible Equity 2016-2025 | SISI

Current and historical return on tangible equity values for SHINECO (SISI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
SHINECO Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.04B $0.01B -1114.29%
2024-12-31 $-0.03B $-0.01B 415.38%
2024-09-30 $-0.03B $-0.01B 313.51%
2024-06-30 $-0.02B $0.02B 179.59%
2024-03-31 $-0.01B $-0.03B 50.91%
2023-12-31 $-0.01B $-0.02B 560.00%
2023-09-30 $-0.01B $-0.02B -43.64%
2023-06-30 $-0.01B $0.02B -45.22%
2023-03-31 $-0.02B $0.02B -46.15%
2022-12-31 $-0.02B $0.04B -41.10%
2022-09-30 $-0.02B $0.04B -39.74%
2022-06-30 $-0.03B $0.03B -71.05%
2022-03-31 $-0.03B $0.04B -73.62%
2021-12-31 $-0.04B $0.04B -81.40%
2021-09-30 $-0.05B $0.04B -96.77%
2021-06-30 $-0.03B $0.04B -59.53%
2021-03-31 $-0.02B $0.05B -38.98%
2020-12-31 $-0.02B $0.06B -30.16%
2020-09-30 $-0.01B $0.07B -9.02%
2020-06-30 $-0.01B $0.07B -10.45%
2020-03-31 $-0.01B $0.07B -7.33%
2019-12-31 $0.00B $0.07B -2.87%
2019-09-30 $0.00B $0.07B -1.43%
2019-06-30 $0.00B $0.07B 2.84%
2019-03-31 $0.00B $0.07B -1.42%
2018-12-31 $0.01B $0.07B 7.02%
2018-09-30 $0.01B $0.07B 11.43%
2018-06-30 $0.01B $0.07B 11.64%
2018-03-31 $0.01B $0.07B 17.98%
2017-12-31 $0.01B $0.07B 14.29%
2017-09-30 $0.01B $0.07B 13.22%
2017-06-30 $0.01B $0.06B 13.73%
2017-03-31 $0.01B $0.06B 12.73%
2016-12-31 $0.01B $0.06B 17.39%
2016-09-30 $0.01B $0.06B 30.48%
2016-06-30 $0.01B $0.05B 65.31%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.003B $0.010B
Shineco, Inc. is principally engaged in the production and distribution of herbal medicines, organic agricultural produce, specialized textiles and other health and well-being focused plant-based products primarily in China. Shineco, Inc. is headquartered in Beijing, China.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.473B 31.72
Zoetis (ZTS) United States $65.038B 23.55
Daiichi Sankyo, - (DSNKY) Japan $47.207B 24.19
Takeda Pharmaceutical (TAK) Japan $45.406B 9.27
BeOne Medicines - (ONC) Cayman Islands $32.718B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.600B 0.00
Summit Therapeutics (SMMT) United States $21.181B 0.00
Merck (MKKGY) Germany $15.953B 11.69
Shionogi (SGIOY) Japan $15.091B 15.12
United Therapeutics (UTHR) United States $13.641B 11.80
Neurocrine Biosciences (NBIX) United States $12.738B 38.00
Orion OYJ (ORINY) Finland $11.709B 28.22
IPSEN (IPSEY) France $10.075B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.507B 0.00
Corcept Therapeutics (CORT) United States $7.431B 62.41
Stevanato Group S.p.A (STVN) Italy $7.283B 42.95
Grifols, S.A (GRFS) Spain $7.206B 0.00
Ionis Pharmaceuticals (IONS) United States $6.486B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 17.90
Soleno Therapeutics (SLNO) United States $4.091B 0.00
Hypermarcas (HYPMY) Brazil $2.787B 20.95
Crinetics Pharmaceuticals (CRNX) United States $2.671B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.658B 8.93
NewAmsterdam Pharma (NAMS) Netherlands $2.652B 0.00
Procaps Group, S.A (PROCF) Luxembourg $2.534B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.523B 12.02
Centessa Pharmaceuticals (CNTA) United Kingdom $2.290B 0.00
Ocular Therapeutix (OCUL) United States $2.175B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.800B 0.00
ARS Pharmaceuticals (SPRY) United States $1.766B 0.00
Dyne Therapeutics (DYN) United States $1.649B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.528B 22.76
Evotec AG (EVO) Germany $1.332B 0.00
Guardian Pharmacy Services (GRDN) United States $1.325B 0.00
Ardelyx (ARDX) United States $1.253B 0.00
Harrow (HROW) United States $1.211B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.074B 0.00
Akebia Therapeutics (AKBA) United States $0.994B 0.00
Collegium Pharmaceutical (COLL) United States $0.956B 5.16
Enliven Therapeutics (ELVN) United States $0.924B 0.00
Xeris Biopharma Holdings (XERS) United States $0.859B 0.00
ProKidney (PROK) United States $0.843B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.730B 0.00
KalVista Pharmaceuticals (KALV) United States $0.638B 0.00
Zevra Therapeutics (ZVRA) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.605B 0.00
Bioventus (BVS) United States $0.599B 14.58
Elite Pharmaceuticals (ELTP) United States $0.581B 0.00
Organogenesis (ORGO) United States $0.571B 0.00
Tourmaline Bio (TRML) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.559B 0.00
USANA Health Sciences (USNA) United States $0.541B 10.88
Xencor (XNCR) United States $0.533B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.533B 5.51
Oruka Therapeutics (ORKA) United States $0.531B 0.00
Siga Technologies (SIGA) United States $0.520B 6.42
Savara (SVRA) United States $0.474B 0.00
Aquestive Therapeutics (AQST) United States $0.396B 0.00
Esperion Therapeutics (ESPR) United States $0.381B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.336B 0.00
Nanobiotix S.A (NBTX) France $0.325B 0.00
AleAnna (ANNA) United States $0.315B 0.00
Aldeyra Therapeutics (ALDX) United States $0.313B 0.00
Altimmune (ALT) United States $0.292B 0.00
Nektar Therapeutics (NKTR) United States $0.279B 0.00
Heron Therapeutics (HRTX) United States $0.276B 0.00
Nature's Sunshine Products (NATR) United States $0.272B 17.70
4D Molecular Therapeutics (FDMT) United States $0.265B 0.00
Larimar Therapeutics (LRMR) United States $0.241B 0.00
Galectin Therapeutics (GALT) United States $0.239B 0.00
OmniAb (OABI) United States $0.236B 0.00
MediWound (MDWD) Israel $0.199B 0.00
China SXT Pharmaceuticals (SXTC) China $0.174B 0.00
Lyell Immunopharma (LYEL) United States $0.171B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Aclaris Therapeutics (ACRS) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Lexeo Therapeutics (LXEO) United States $0.158B 0.00
Korro Bio (KRRO) United States $0.147B 0.00
Avita Medical (RCEL) United States $0.142B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Liminatus Pharma (LIMN) United States $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.112B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
VAXART, INC (VXRT) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.090B 20.47
Avalo Therapeutics (AVTX) United States $0.090B 0.00
Surrozen (SRZN) United States $0.089B 0.00
Cardiol Therapeutics (CRDL) Canada $0.088B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Vivani Medical (VANI) United States $0.082B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
PMV Pharmaceuticals (PMVP) United States $0.079B 0.00
Metagenomi (MGX) United States $0.079B 0.00
Nutriband (NTRB) United States $0.078B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.070B 0.00
BioNxt Solutions (BNXTF) Canada $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.065B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
Telomir Pharmaceuticals (TELO) United States $0.055B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.18
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
Plus Therapeutics (PSTV) United States $0.046B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
Scienture Holdings (SCNX) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.033B 0.00
Cosmos Health (COSM) United States $0.033B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Mural Oncology (MURA) Ireland $0.031B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
CASI Pharmaceuticals (CASI) China $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.007B 0.00
BioVie (BIVI) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 12.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.20
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00